MIRA Pharmaceuticals is a clinical-stage biotechnology company advancing novel oral therapies across pain and metabolic disease.
MIRA was built around a straightforward idea: established biological mechanisms can hold therapeutic potential even when existing medicines have limitations. We design differentiated molecules intended to build on that biology while addressing limitations of earlier approaches.
Connect With MIRA
Connect with us to learn more about our programs, science, and corporate development.